Keyphrases
Immunogenicity
100%
Vaccine Candidate
100%
Serotype 2
100%
Phase 1 Study
100%
Tetravalent Dengue Vaccine
100%
Intradermal Administration
100%
Neutralizing Antibodies
60%
Serotype 1
60%
Syrinx
40%
Serotype 3
40%
Placebo
20%
Next-generation Vaccines
20%
Older Subjects
20%
Treatment Group
20%
Vaccination Protocols
20%
Antibody Titer
20%
Titer
20%
Adverse Events
20%
World Health Organization
20%
Serious Adverse Events
20%
Seroconversion
20%
Vaccine Dose
20%
Laboratory Measurements
20%
Two-dose
20%
Dengue Vaccine
20%
Seroconversion Rate
20%
Serotype 4
20%
Storage Conditions
20%
Dengue Disease
20%
Phase 1b Study
20%
Early Cessation
20%
Safety Signal
20%
Dengue Vaccination
20%
Injector
20%
Diary Card
20%
Planned Schedule
20%
Concurrent Search
20%
Two-center
20%
Lyophilized Preparations
20%
Simultaneous Injection
20%
Immunology and Microbiology
Immunogenicity
100%
Serotype
100%
Dengue Vaccine
100%
Neutralizing Antibody
50%
Low Drug Dose
50%
Vaccine Efficacy
33%
Vaccination Policy
33%
Seroconversion
33%
Titer
16%
Antibody Titer
16%
Dengue Fever
16%
Spine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Immunogenicity
100%
Dengue Vaccine
100%
Neutralizing Antibody
60%
Adverse Event
40%
Vaccination Policy
40%
Jet Injector
40%
Disease
20%
Placebo
20%
Dengue
20%